From all our experience in targeted drug delivery for cancer treatment and regenerative medicine, a new project arose to treat autoimmune diseases such as inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, etc.
Ecopol Tech has created a new drug delivery technology to specifically target and penetrate the membrane of dendritic cells
to help self-regulate auto-inflammation in autoimmune diseases.
If you want to know more contact us.
Or check out our publications:
- G. Flórez-Grau, P. Rocas, R. Cabezón, C. España, J. Panés, J. Rocas, et al., Nanoencapsulated Budesonide in Self-Stratified Polyurethane-Polyurea Nanoparticles is Highly Effective in Inducing Human Tolerogenic Dendritic Cells (Int. J. Pharm., 2016, DOI: 10.1016/j.ijpharm.2016.07.056).